Study data also showed prolonged progression-free survival with 177Lu-edotreotide compared to everolimus across patient subgroupsBerlin, ...

Study data also showed prolonged progression-free survival with 177 Lu-edotreotide compared to everolimus across patient subgroups; Berlin, Germany, October 18, 2025 – ITM Isoto ...

Scientists led by Northwestern University and Soochow University in China have built the first perovskite-based detector that ...

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess ...

Researchers from Alliance Medical Ltd. performed a retrospective case series review of oncologic FDG PET-CT scans in patients taking GLP-1 agonists. They observed several atypical patterns of tracer ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

Interim dosimetry data from COMPETE informed the design of ITM’s ongoing Phase 3 COMPOSE trial with ITM-11 in well-differentiated, aggressive Grade 2 or Grade 3 SSTR-positive GEP-NET tumors as well as ...

A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...

This publication, which accompanies Nuclear Cardiology: Its Role in Cost Effective Care (IAEA Human Health Series No. 18), discusses non-invasive imaging modalities with an emphasis on myocardial ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...